Purvalanol A, inhibitor of cyclin-dependent kinases attenuates proliferation of cells in the dentate gyrus of the adult rat hippocampus.
Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue 6
Abstract
Several recent findings indicate that intensity of neurogenesis in adult brain might be regulated by enzymes involved in the cell cycle. Therefore, in the present study, we investigated whether the inhibition of cyclin-dependent kinases (CDKs) evoked by intraventricular administration of purvalanol A may influence the proliferation of cells in the dentate gyrus (DG) of the rat hippocampus. Purvalanol A, a selective inhibitor of CDKs, was injected into the brain lateral ventricle at concentrations of 4 nmol/3 mul or 40 nmol/3 mul. The number of proliferating cells was determined by analysis of nuclear incorporation of BrdU (100 mg/kg, ip). BrdU was given at two times points (0.5 h and 2.5 h) after vehicle or purvalanol A injection. It was found that purvalanol A given 0.5 h before BrdU injection did not cause any significant changes in the number of BrdU-positive nuclei in the DG. However, a higher dose of purvalanol A i.e. 40 nmol/3 mul given 2.5 h before BrdU administration significantly decreased the number of BrdU-positive nuclei in the DG of the hippocampus (by approximately 35%). In contrast, a lower dose of the CDKs inhibitor (4 nmol/3 mul) given at the same time point did not affect the number of BrdU-positive cells in the DG. It appears that purvalanol A inhibits the hippocampal proliferation in concentration- and time-dependent manner. Moreover, the present data indicate that CDKs are involved in generation of new cells in the adult rat hippocampus.
Authors and Affiliations
Marzena Maćkowiak, Wacław Kolasiewicz, Katarzyna Markowicz-Kula, Krzysztof Wędzony
Keywords
Related Articles
- EP ID EP83600
- DOI -
- Views 138
- Downloads 0
Influence of orphenadrine upon the protective activity of various antiepileptics in the maximal electroshock-induced convulsions in mice.
Orphenadrine is an anticholinergic drug used in the treatment of Parkinson's disease, and is also known to exert nonspecific antagonistic activity at the phencyclidine binding site of the N-methyl-D-aspartate (NMDA) rece...
Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells.
Human umbilical vein endothelial cells (HUVECs) were established as in vitro models for the modulation of endothelial function and cell viability by statins. Emphasis was placed on the biphasic effects of the drugs on ni...
Evaluation of liver glycogen catabolism during hypercortisolism induced by the administration of dexamethasone in rats.
Background: The contribution of liver glycogen catabolism to hyperglycemia and glucose intolerance induced by pharmacological hypercortisolism were investigated. Methods: For this purpose, adult male Wistar rats that rec...
Atherosclerotic risk among children taking antiepileptic drugs.
Epilepsy is a common chronic neurological disorder that requires long-term or sometimes lifetime therapy. Recent evidence indicates that prolonged use of antiepileptic drugs (AEDs) might modify some vascular risk factors...
Fluvastatin does not elevate periosteal osteogenesis induced by Moloney sarcomavirus (MSV) in mice.
Several studies have demonstrated the pleiotropic effects of statins. Since Wang and associates reported that in rabbits lovastatin reduced steroid-induced bone loss, numerous authors have confirmed these data, however,...